Bloomage Biotechnology Corp Ltd
SSE:688363
Bloomage Biotechnology Corp Ltd
Long-Term Investments
Bloomage Biotechnology Corp Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
Long-Term Investments
¥585m
|
CAGR 3-Years
173%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Long-Term Investments
¥928.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Long-Term Investments
¥3.6B
|
CAGR 3-Years
106%
|
CAGR 5-Years
349%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Long-Term Investments
¥414.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Long-Term Investments
¥1.4B
|
CAGR 3-Years
181%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bloomage Biotechnology Corp Ltd
Glance View
Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.
See Also
What is Bloomage Biotechnology Corp Ltd's Long-Term Investments?
Long-Term Investments
585m
CNY
Based on the financial report for Mar 31, 2025, Bloomage Biotechnology Corp Ltd's Long-Term Investments amounts to 585m CNY.
What is Bloomage Biotechnology Corp Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
87%
Over the last year, the Long-Term Investments growth was 42%. The average annual Long-Term Investments growth rates for Bloomage Biotechnology Corp Ltd have been 173% over the past three years , 87% over the past five years .
You don't have any saved screeners yet